Filing Details
- Accession Number:
- 0001209191-22-001678
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-05 16:23:58
- Reporting Period:
- 2022-01-03
- Accepted Time:
- 2022-01-05 16:23:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1828443 | Ortho Clinical Diagnostics Holdings Plc | OCDX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1436707 | M Christopher Smith | C/O Ortho Clinical Diagnostics Holdings 1001 Route 202 Raritan NJ 08869 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, $0.00001 Par Value | Acquisiton | 2022-01-03 | 100,000 | $12.56 | 467,360 | No | 4 | M | Direct | |
| Ordinary Shares, $0.00001 Par Value | Disposition | 2022-01-03 | 100,000 | $21.10 | 367,360 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares, $0.00001 Par Value | Stock Option | Disposition | 2022-01-03 | 100,000 | $0.00 | 100,000 | $12.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 935,710 | 2029-12-20 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
- Represents the weighted average sales price for the price increments ranging from $21.0000 to $21.4000
- The stock option vests in three equal annual installments beginning on September 9, 2020.
Billionaire Hedge Funds
